Q2 2019
Released Aug 7, 2019, after the close
10-Q filed Aug 7, 2019, 38 days after period end · 0001493152-19-011792
Q2 2019 · 10-Q
Revenue$2.31M$2.31M +69.0% vs Q2 2018+30.5% vs Q1 2019
Net Income-$942.00K-$942.00K N/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$0.14-$0.14 N/M vs Q2 2018N/M vs Q1 2019
Gross Profit$1,367,000+64.7%
Operating Income-$868,000N/M
Operating Cash Flowderived-$1,329,000N/M
Margins · derived
Gross margin59.2%−1.6 pt vs Q2 2018
Operating margin-37.6%+10.2 pt vs Q2 2018
Net margin-40.8%+9.1 pt vs Q2 2018
What the release said
The release
Same quarter
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $2.31M | $1.37M | $859.00K | $509.00K |
| Net Income | -$942.00K | -$682.00K | -$786.00K | -$835.00K |
| EPS Diluted | -$0.14 | -$0.10 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR